Cytosorbents financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

사이토소벤츠NASDAQ:CTSO · Nasdaq · Healthcare

$3.96-2.10%

2026-10-05 close

Cytosorbents's published financial data is dated 2026-10-04. 2024 revenue was $36M. 2024 operating profit was −$17M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy